In vitro and in vivo characterization of [177Lu]DOTA-G-02113 and [68Ga]DOTA-G-02113 presented Oct. 17, 2019
First patient enrolled in phase II study of novel cystic fibrosis treatment, BI-1265162 Oct. 17, 2019
RSS